Prof. Dr. Özlem Ercelep

Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature

Current Problems in Cancer, 2020

DOI 10.1016/j.currproblcancer.2020.100668 PMID 33127167 11 Zitationen (OpenAlex) Quelle: OpenAlex

Does insulin resistance predict complete response in breast cancer patients who underwent neoadjuvant treatment?

Cancer Research, 2020

DOI 10.1158/1538-7445.sabcs19-p2-16-18 Quelle: ORCID

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

World Journal of Surgical Oncology, 2020

DOI 10.1186/s12957-020-02019-y PMID 32907593 25 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment

Clinical Neurology and Neurosurgery, 2020

DOI 10.1016/j.clineuro.2020.105976 PMID 32531614 6 Zitationen (OpenAlex) Quelle: OpenAlex

Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

International Journal of Clinical Oncology, 2020

DOI 10.1007/s10147-020-01767-x PMID 32797321 3 Zitationen (OpenAlex) Quelle: OpenAlex

Comparison of Seventh and Eighth Editions of TNM Staging Classification and Evaluation of Survivals in Operated Non-Small Cell Lung Carcinomas:Single Center Experience

Eurasian Journal of Medical Investigation, 2020

DOI 10.14744/ejmi.2020.81008 Quelle: OpenAlex

Evaluation of Recent Targeted Treatments

Güncel Göğüs Hastalıkları Serisi, 2020

DOI 10.5152/gghs.2018.044 Quelle: OpenAlex

The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future

Bulletin of Urooncology, 2020

DOI 10.4274/uob.galenos.2020.1447 Frei zugänglicher VolltextQuelle: OpenAlex

Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment – Single-Center Experience

Turkish Journal of Oncology, 2020

DOI 10.5505/tjo.2020.2207 Frei zugänglicher VolltextQuelle: OpenAlex

Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

PubMed, 2019

PMID 31786850 1 Zitation (Europe PMC) Quelle: OpenAlex

P2.06-22 Is Laboratory Prognostic Index a Valuable Prognostic Index for Malignant Pleural Mesothelioma?

Journal of Thoracic Oncology, 2019

DOI 10.1016/j.jtho.2019.08.1640 Frei zugänglicher VolltextQuelle: OpenAlex

Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019

DOI 10.1007/s12094-018-1949-6 PMID 30229391 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Neoadjuvant treatment in patients with locally advanced gastric cancer.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.4_suppl.127 3 Zitationen (OpenAlex) Quelle: ORCID

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219890032 PMID 31793376 12 Zitationen (OpenAlex) Quelle: OpenAlex

A rare case of primary rectal choriocarcinoma and review of the literature

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219875510 PMID 31547751 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219879757 PMID 31615346 20 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.

PubMed, 2019

PMID 31646797 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

Annals of Oncology, 2019

DOI 10.1093/annonc/mdz259.007 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Glioblastomda İlk Seri Sistemik Tedavi

Turkiye Klinikleri Medical Oncology - Special Topics, 2019

Quelle: OpenAlex

P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

Journal of Thoracic Oncology, 2018

DOI 10.1016/j.jtho.2018.08.1593 Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic factors in early stage lung cancer patients: Retrospective single center data.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.15_suppl.e20500 Quelle: OpenAlex

P3.16-48 Is Preoperative SUV(Max) of Primary Tumor a Predictor of Relapse for Operable Non-Small Cell Lung Cancer?

Journal of Thoracic Oncology, 2018

DOI 10.1016/j.jtho.2018.08.1955 Frei zugänglicher VolltextQuelle: OpenAlex

Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas

Current Problems in Cancer, 2018

DOI 10.1016/j.currproblcancer.2018.06.014 PMID 30104029 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy.

Current problems in cancer, 2018

DOI 10.1016/j.currproblcancer.2018.04.003 PMID 29880396 12 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Chordoma: a case series and review of the literature

Journal of Medical Case Reports, 2018

DOI 10.1186/s13256-018-1784-y PMID 30145982 34 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Association of lymphadenectomy and survival in epithelial ovarian cancer

Current Problems in Cancer, 2018

DOI 10.1016/j.currproblcancer.2018.08.002 PMID 30149960 18 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience

Current Problems in Cancer, 2018

DOI 10.1016/j.currproblcancer.2018.07.004 PMID 30122267 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Modified Glasgow prognostic score, prognostic nutritional index and ECOG score could be new prognostic factors for survival in metastatic gastric cancer

Annals of Oncology, 2017

DOI 10.1093/annonc/mdx369.049 Frei zugänglicher VolltextQuelle: OpenAlex

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Journal of B.U.ON., 2017

PMID 29135102 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2017.35.15_suppl.e15009 1 Zitation (OpenAlex) Quelle: OpenAlex

P1.03-040 Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

Journal of Thoracic Oncology, 2017

DOI 10.1016/j.jtho.2017.09.844 Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

Tumor Biology, 2016

DOI 10.1007/s13277-015-4776-1 PMID 26753955 11 Zitationen (Europe PMC) Quelle: OpenAlex

Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

Oncology Research and Treatment, 2016

DOI 10.1159/000444272 PMID 27030981 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Clinical Colorectal Cancer, 2016

DOI 10.1016/j.clcc.2016.04.013 PMID 27247089 17 Zitationen (Europe PMC) Quelle: OpenAlex

Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology

Tumor Biology, 2016

DOI 10.1007/s13277-016-5076-0 PMID 27173124 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

Tumor Biology, 2015

DOI 10.1007/s13277-015-4359-1 PMID 26553363 13 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

Clinical & Translational Oncology, 2015

DOI 10.1007/s12094-015-1283-1 PMID 25786367 23 Zitationen (OpenAlex) Quelle: OpenAlex

The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

Clinical & Translational Oncology, 2015

DOI 10.1007/s12094-015-1408-6 PMID 26459249 3 Zitationen (OpenAlex) Quelle: OpenAlex

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.3_suppl.60 1 Zitation (OpenAlex) Quelle: OpenAlex

Treatment and prognosis in mucosal melanoma: An Anatolian Society of Medical Oncology Study.

Journal of Clinical Oncology, 2014

DOI 10.1200/jco.2014.32.15_suppl.e20051 Quelle: OpenAlex